Wayne Grody

Wayne W Grody

Professor, Pathology and Laboratory Medicine, University of California Los Angeles

Professor, Human Genetics, University of California Los Angeles

Professor, Pediatrics, University of California Los Angeles

(310) 825-5648

UC Profile
http://www.uclahealth.org/WayneGrody

Publications

  1. Cushman-Vokoun A, Schmidt RJ, Hiemenz MC, Fung M, Zhang BM, Bradshaw G, Gandhi M, Yao J, Yohe S, Beckman A, Grody WW, Giannikopoulos P. A Primer on Gene Editing: What Does It Mean for Pathologists?. Archives of pathology & laboratory medicine, 2023.
  2. Cushman-Vokoun A, Schmidt RJ, Hiemenz MC, Fung M, Zhang BM, Bradshaw G, Gandhi M, Yao J, Yohe S, Beckman A, Grody WW, Giannikopoulos P. A Primer on Gene Editing.. Archives of pathology & laboratory medicine, 2023.
  3. Chubick A, Wang E, Au C, Grody WW, Ophoff RA. Large-Scale Whole Genome Sequence Analysis of >22,000 Subjects Provides no Evidence of FMR1 Premutation Allele Involvement in Autism Spectrum Disorder.. Genes, 2023.
  4. Mulvihill JJ, Grody WW. The Gregor Mendel Bicentennial Tribute-Enduring Mementos of the Founder of Genetics.. JAMA, 2023.
  5. Giacoletto CJ, Rotter JI, Grody WW, Schiller MR. Synonymous Variants of Uncertain Silence.. International journal of molecular sciences, 2023.
  6. Deignan JL, Gregg AR, Grody WW, Guo MH, Kearney H, Monaghan KG, Raraigh KS, Taylor J, Zepeda-Mendoza CJ, Ziats C, ACMG Board of Directors. Electronic address: documents@acmg.net. Updated recommendations for CFTR carrier screening: A position statement of the American College of Medical Genetics and Genomics (ACMG).. Genetics in medicine : official journal of the American College of Medical Genetics, 2023.
  7. Best RG, Khushf G, Rabin-Havt SS, Clayton EW, Grebe TA, Hagenkord J, Topper S, Fivecoat J, Chen M, Grody WW, ACMG Social, Ethical and Legal Issues Committee. Electronic address: documents@acmg.net. Stewardship of patient genomic data: A policy statement of the American College of Medical Genetics and Genomics (ACMG).. Genetics in medicine : official journal of the American College of Medical Genetics, 2021.
  8. Hamosh A, Amberger JS, Bocchini CA, Bodurtha J, Bult CJ, Chute CG, Cutting GR, Dietz HC, Firth HV, Gibbs RA, Grody WW, Haendel MA, Lupski JR, Posey JE, Robinson PN, Schriml LM, Scott AF, Sobreira NL, Valle D, Wu N, Rasmussen SA. Response to Biesecker et al.. American journal of human genetics, 2021.
  9. Zhao Y, Wang LK, Eskin A, Kang X, Fajardo VM, Mehta Z, Pineles S, Schmidt RJ, Nagiel A, Satou G, Garg M, Federman M, Reardon LC, Lee SL, Biniwale R, Grody WW, Halnon N, Khanlou N, Quintero-Rivera F, Alejos JC, Nakano A, Fishbein GA, Van Arsdell GS, Nelson SF, Touma M. Recessive ciliopathy mutations in primary endocardial fibroelastosis: a rare neonatal cardiomyopathy in a case of Alstrom syndrome.. Journal of molecular medicine (Berlin, Germany), 2021.
  10. Lin I, Afshar Y, Goldstein J, Grossman J, Grody WW, Quintero-Rivera F. Central 22q11.2 deletion (LCR22 B-D) in a fetus with severe fetal growth restriction and a mother with severe systemic lupus erythematosus: Further evidence of CRKL haploinsufficiency in the pathogenesis of 22q11.2 deletion syndrome.. American journal of medical genetics. Part A, 2021.
  11. Bhatt S, Taylor AK, Lozano R, Grody WW, Griffin JH, ACMG Professional Practice and Guidelines Committee. Addendum: American College of Medical Genetics consensus statement on factor V Leiden mutation testing.. Genetics in medicine : official journal of the American College of Medical Genetics, 2021.
  12. Gardner JM, Grody WW. Memories of Gene Herbek, MD.. Archives of pathology & laboratory medicine, 2021.
  13. Zhao Y, Kang X, Barsegian A, He J, Guzman A, Lau RP, Biniwale R, Wadhra M, Reemtsen B, Garg M, Halnon N, Quintero-Rivera F, Grody WW, UCLA Congenital Heart Defects BioCore Faculty, Van Arsdell G, Nelson SF, Touma M. Gene-environment regulation of chamber-specific maturation during hypoxemic perinatal circulatory transition.. Journal of molecular medicine (Berlin, Germany), 2020.
  14. Tu M, Cheng J, Chen YL, Jea WC, Chen WL, Chen CJ, Ho CL, Huang WL, Lin CC, Su WC, Ye Q, Deignan J, Grody W, Li F, Chia D, Wei F, Liao W, Wong DTW, Strom CM. Electric Field-Induced Release and Measurement (EFIRM): Characterization and Technical Validation of a Novel Liquid Biopsy Platform in Plasma and Saliva.. The Journal of molecular diagnostics : JMD, 2020.
  15. Deignan JL, Astbury C, Cutting GR, Del Gaudio D, Gregg AR, Grody WW, Monaghan KG, Richards S, ACMG Laboratory Quality Assurance Committee. CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG).. Genetics in medicine : official journal of the American College of Medical Genetics, 2020.
  16. Yazdani S, Badjatiya A, Dorrani N, Lee H, Grody WW, Nelson SF, Dipple KM. Genetic characterization and long-term management of severely affected siblings with intellectual developmental disorder with cardiac arrhythmia syndrome.. Molecular genetics and metabolism reports, 2020.
  17. Delatycki MB, Alkuraya F, Archibald A, Castellani C, Cornel M, Grody WW, Henneman L, Ioannides AS, Kirk E, Laing N, Lucassen A, Massie J, Schuurmans J, Thong MK, van Langen I, Zlotogora J. International perspectives on the implementation of reproductive carrier screening.. Prenatal diagnosis, 2019.
  18. Ngo KJ, Rexach JE, Lee H, Petty LE, Perlman S, Valera JM, Deignan JL, Mao Y, Aker M, Posey JE, Jhangiani SN, Coban-Akdemir ZH, Boerwinkle E, Muzny D, Nelson AB, Hassin-Baer S, Poke G, Neas K, Geschwind MD, Grody WW, Gibbs R, Geschwind DH, Lupski JR, Below JE, Nelson SF, Fogel BL. A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disorders.. Human mutation, 2019.
  19. Eno CC, Barton SK, Dorrani N, Cederbaum SD, Deignan JL, Grody WW. Confidential genetic testing and electronic health records: A survey of current practices among Huntington disease testing centers.. Molecular genetics & genomic medicine, 2019.
  20. Grody WW. The transformation of medical genetics by clinical genomics: hubris meets humility.. Genetics in medicine : official journal of the American College of Medical Genetics, 2019.
  21. Jacob N, Dasharathy SS, Bui V, Benhammou JN, Grody WW, Singh RR, Pisegna JR. Generalized Cytokine Increase in the Setting of a Multisystem Clinical Disorder and Carcinoid Syndrome Associated with a Novel NLRP12 Variant.. Digestive diseases and sciences, 2019.
  22. Lin HJ, Lan YT, Silka MJ, Halnon NJ, Villa-Lopez E, Arenas N, Escobedo F, Montoya R, Valdez S, Rajabi Shishvan O, Sedano S, Marr EH, Lauzon M, Moosa AS, Ko KJ, Shoji EC, Clark AM, Smith LM, Criley JM, Grody WW, Chen YI, Taylor KD, Guo X, Soyata T, Rotter JI, Chien T, Chou P, Chang RK. Home use of a compact, 12‑lead ECG recording system for newborns.. Journal of electrocardiology, 2019.
  23. Richards CS, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG/AMP Interpretation of Sequence Variants Work Group 2015. Response to Biesecker and Harrison.. Genetics in medicine : official journal of the American College of Medical Genetics, 2018.
  24. Wei F, Strom CM, Cheng J, Lin CC, Hsu CY, Soo Hoo GW, Chia D, Kim Y, Li F, Elashoff D, Grognan T, Tu M, Liao W, Xian R, Grody WW, Su WC, Wong DTW. Electric Field-Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment.. The Journal of molecular diagnostics : JMD, 2018.
  25. Datkhaeva I, Arboleda VA, Senaratne TN, Nikpour G, Meyerson C, Geng Y, Afshar Y, Scibetta E, Goldstein J, Quintero-Rivera F, Crandall BF, Grody WW, Deignan J, Janzen C. Identification of novel PIEZO1 variants using prenatal exome sequencing and correlation to ultrasound and autopsy findings of recurrent hydrops fetalis.. American journal of medical genetics. Part A, 2018.
  26. Kansal R, Grody WW, Zhou J, Dong L, Li X. The Value of T-Cell Receptor γ (TRG) Clonality Evaluation by Next-Generation Sequencing in Clinical Hematolymphoid Tissues.. American journal of clinical pathology, 2018.
  27. Mullegama SV, Klein SD, Nguyen DC, Kim A, Signer R, Fox M, Dorrani N, Hendershot A, Mardach R, Suddath R, Dipple K, Vilain E, Wong DA, Deignan JL, D Cederbaum S, Grody WW, Martinez-Agosto JA. Is it time to retire fragile X testing as a first-tier test for developmental delay, intellectual disability, and autism spectrum disorder?. Genetics in medicine : official journal of the American College of Medical Genetics, 2017.
  28. Kaul KL, Sabatini LM, Tsongalis GJ, Caliendo AM, Olsen RJ, Ashwood ER, Bale S, Benirschke R, Carlow D, Funke BH, Grody WW, Hayden RT, Hegde M, Lyon E, Murata K, Pessin M, Press RD, Thomson RB. The Case for Laboratory Developed Procedures: Quality and Positive Impact on Patient Care.. Academic pathology, 2017.
  29. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG. CORRIGENDUM: ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.. Genetics in medicine : official journal of the American College of Medical Genetics, 2017.
  30. Mullegama SV, Jensik P, Li C, Dorrani N, UCLA Clinical Genomics Center, Kantarci S, Blumberg B, Grody WW, Strom SP. Coupling clinical exome sequencing with functional characterization studies to diagnose a patient with familial Mediterranean fever and MED13L haploinsufficiency syndromes.. Clinical case reports, 2017.
  31. Allyse M, Aypar U, Bonhomme N, Darilek S, Dougherty M, Farrell R, Grody W, Highsmith WE, Michie M, Nunes M, Otto L, Pabst R, Palomaki G, Runke C, Sharp RR, Skotko B, Stoll K, Wick M. Offering Prenatal Screening in the Age of Genomic Medicine: A Practical Guide.. Journal of women's health (2002), 2017.
  32. Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline Summary From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.. Journal of oncology practice, 2017.
  33. Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Bryan Rumble R, Temple-Smolkin R, B Ventura C, Nowak JA. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.. Archives of pathology & laboratory medicine, 2017.
  34. Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.. The Journal of molecular diagnostics : JMD, 2017.
  35. Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017.
  36. Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA. Molecular Biomarkers for the Evaluation of Colorectal Cancer.. American journal of clinical pathology, 2017.
  37. Grody WW. Prenatal Carrier Screening-Reply.. JAMA, 2016.
  38. Benhammou JN, Phan J, Lee H, Ghassemi K, Parsons W, Grody WW, Pisegna JR. A Sodium Channel Myotonia Presenting with Intermittent Dysphagia as a Manifestation of a Rare SCN4A Variant.. Journal of molecular neuroscience : MN, 2016.
  39. Ge X, Gong H, Dumas K, Litwin J, Phillips JJ, Waisfisz Q, Weiss MM, Hendriks Y, Stuurman KE, Nelson SF, Grody WW, Lee H, Kwok PY, Shieh JT. Missense-depleted regions in population exomes implicate ras superfamily nucleotide-binding protein alteration in patients with brain malformation.. NPJ genomic medicine, 2016.
  40. Grody WW. Where to Draw the Boundaries for Prenatal Carrier Screening.. JAMA, 2016.
  41. Grody WW. The next generation of cancer management.. Cancer biology & medicine, 2016.
  42. Mooney KL, Choy W, Woodard J, Xian RR, Deal TM, Kendle RF, Said J, Grody W, Yang I. Primary central nervous system gamma delta cytotoxic T-cell lymphoma.. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2016.
  43. Deignan JL, Grody WW. Molecular Diagnosis of Cystic Fibrosis.. Current protocols in human genetics, 2016.
  44. Kansal R, Li X, Shen J, Samuel D, Laningham F, Lee H, Panigrahi GB, Shuen A, Kantarci S, Dorrani N, Reiss J, Shintaku P, Deignan JL, Strom SP, Pearson CE, Vilain E, Grody WW. An infant with MLH3 variants, FOXG1-duplication and multiple, benign cranial and spinal tumors: A clinical exome sequencing study.. Genes, chromosomes & cancer, 2015.
  45. Ji J, Lee H, Argiropoulos B, Dorrani N, Mann J, Martinez-Agosto JA, Gomez-Ospina N, Gallant N, Bernstein JA, Hudgins L, Slattery L, Isidor B, Le Caignec C, David A, Obersztyn E, Wisniowiecka-Kowalnik B, Fox M, Deignan JL, Vilain E, Hendricks E, Horton Harr M, Noon SE, Jackson JR, Wilkens A, Mirzaa G, Salamon N, Abramson J, Zackai EH, Krantz I, Innes AM, Nelson SF, Grody WW, Quintero-Rivera F. DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies.. European journal of human genetics : EJHG, 2015.
  46. Cherukuri DP, Deignan JL, Das K, Grody WW, Herschman H. Instability of a dinucleotide repeat in the 3'-untranslated region (UTR) of the microsomal prostaglandin E synthase-1 (mPGES-1) gene in microsatellite instability-high (MSI-H) colorectal carcinoma.. Molecular oncology, 2015.
  47. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.. Genetics in medicine : official journal of the American College of Medical Genetics, 2015.
  48. Arboleda VA, Lee H, Dorrani N, Zadeh N, Willis M, Macmurdo CF, Manning MA, Kwan A, Hudgins L, Barthelemy F, Miceli MC, Quintero-Rivera F, Kantarci S, Strom SP, Deignan JL, UCLA Clinical Genomics Center, Grody WW, Vilain E, Nelson SF. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay.. American journal of human genetics, 2015.
  49. Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero-Rivera F, Das K, Toy T, Harry B, Yourshaw M, Fox M, Fogel BL, Martinez-Agosto JA, Wong DA, Chang VY, Shieh PB, Palmer CG, Dipple KM, Grody WW, Vilain E, Nelson SF. Clinical exome sequencing for genetic identification of rare Mendelian disorders.. JAMA, 2014.
  50. Fogel BL, Lee H, Deignan JL, Strom SP, Kantarci S, Wang X, Quintero-Rivera F, Vilain E, Grody WW, Perlman S, Geschwind DH, Nelson SF. Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia.. JAMA neurology, 2014.
  51. Aziz N, Zhao Q, Bry L, Driscoll DK, Funke B, Gibson JS, Grody WW, Hegde MR, Hoeltge GA, Leonard DG, Merker JD, Nagarajan R, Palicki LA, Robetorye RS, Schrijver I, Weck KE, Voelkerding KV. College of American Pathologists' laboratory standards for next-generation sequencing clinical tests.. Archives of pathology & laboratory medicine, 2014.
  52. Grody WW, Vilain E, Nelson SF. Interpreting whole-genome sequencing.. JAMA, 2014.
  53. Hu C, Kasten J, Park H, Bhargava R, Tai DS, Grody WW, Nguyen QG, Hauschka SD, Cederbaum SD, Lipshutz GS. Myocyte-mediated arginase expression controls hyperargininemia but not hyperammonemia in arginase-deficient mice.. Molecular therapy : the journal of the American Society of Gene Therapy, 2014.
  54. Strom SP, Lozano R, Lee H, Dorrani N, Mann J, O'Lague PF, Mans N, Deignan JL, Vilain E, Nelson SF, Grody WW, Quintero-Rivera F. De Novo variants in the KMT2A (MLL) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing.. BMC medical genetics, 2014.
  55. Loh JC, Cassarino DS, Grody WW, Chiu MW, Pinter-Brown LC. A case of mycosis fungoides transmitted from donor to recipient, and review of literature of T-cell malignancies after transplantation.. Clinical lymphoma, myeloma & leukemia, 2014.
  56. Strom SP, Lee H, Das K, Vilain E, Nelson SF, Grody WW, Deignan JL. Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratory.. Genetics in medicine : official journal of the American College of Medical Genetics, 2014.
  57. Grody WW, Thompson BH, Hudgins L. Whole-exome/genome sequencing and genomics.. Pediatrics, 2013.
  58. Massie J, Castellani C, Grody WW. Carrier screening for cystic fibrosis in the new era of medications that restore CFTR function.. Lancet (London, England), 2013.
  59. Kasten J, Hu C, Bhargava R, Park H, Tai D, Byrne JA, Marescau B, De Deyn PP, Schlichting L, Grody WW, Cederbaum SD, Lipshutz GS. Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse.. Molecular genetics and metabolism, 2013.
  60. Kalman LV, Lubin IM, Barker S, du Sart D, Elles R, Grody WW, Pazzagli M, Richards S, Schrijver I, Zehnbauer B. Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics.. Archives of pathology & laboratory medicine, 2013.
  61. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG, American College of Medical Genetics and Genomics. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.. Genetics in medicine : official journal of the American College of Medical Genetics, 2013.
  62. Grody WW, Thompson BH, Gregg AR, Bean LH, Monaghan KG, Schneider A, Lebo RV. ACMG position statement on prenatal/preconception expanded carrier screening.. Genetics in medicine : official journal of the American College of Medical Genetics, 2013.
  63. Palmer CG, Boudreault P, Baldwin EE, Fox M, Deignan JL, Kobayashi Y, Sininger Y, Grody W, Sinsheimer JS. Deaf genetic testing and psychological well-being in deaf adults.. Journal of genetic counseling, 2013.
  64. Lee EK, Hu C, Bhargava R, Ponnusamy R, Park H, Novicoff S, Rozengurt N, Marescau B, De Deyn P, Stout D, Schlichting L, Grody WW, Cederbaum SD, Lipshutz GS. AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse.. Gene therapy, 2013.
  65. Bavisetty S, Grody WW, Yazdani S. Emergence of pediatric rare diseases: Review of present policies and opportunities for improvement.. Rare diseases (Austin, Tex.), 2013.
  66. Ong FS, Kuo JZ, Wu WC, Cheng CY, Blackwell WL, Taylor BL, Grody WW, Rotter JI, Lai CC, Wong TY. Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.. Journal of personalized medicine, 2013.
  67. Ong FS, Vakil H, Xue Y, Kuo JZ, Shah KH, Lee RB, Bernstein KE, Rimoin DL, Getzug T, Das K, Deignan JL, Rotter JI, Grody WW. The M694V mutation in Armenian-Americans: a 10-year retrospective study of MEFV mutation testing for familial Mediterranean fever at UCLA.. Clinical genetics, 2012.
  68. Schrijver I, Aziz N, Farkas DH, Furtado M, Gonzalez AF, Greiner TC, Grody WW, Hambuch T, Kalman L, Kant JA, Klein RD, Leonard DG, Lubin IM, Mao R, Nagan N, Pratt VM, Sobel ME, Voelkerding KV, Gibson JS. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology.. The Journal of molecular diagnostics : JMD, 2012.
  69. Patrinos GP, Smith TD, Howard H, Al-Mulla F, Chouchane L, Hadjisavvas A, Hamed SA, Li XT, Marafie M, Ramesar RS, Ramos FJ, de Ravel T, El-Ruby MO, Shrestha TR, Sobrido MJ, Tadmouri G, Witsch-Baumgartner M, Zilfalil BA, Auerbach AD, Carpenter K, Cutting GR, Dung VC, Grody W, Hasler J, Jorde L, Kaput J, Macek M, Matsubara Y, Padilla C, Robinson H, Rojas-Martinez A, Taylor GR, Vihinen M, Weber T, Burn J, Qi M, Cotton RG, Rimoin D, International Confederation of Countries Advisory Council. Human Variome Project country nodes: documenting genetic information within a country.. Human mutation, 2012.
  70. Lee EK, Hu C, Bhargava R, Rozengurt N, Stout D, Grody WW, Cederbaum SD, Lipshutz GS. Long-term survival of the juvenile lethal arginase-deficient mouse with AAV gene therapy.. Molecular therapy : the journal of the American Society of Gene Therapy, 2012.
  71. Ong FS, Das K, Wang J, Vakil H, Kuo JZ, Blackwell WL, Lim SW, Goodarzi MO, Bernstein KE, Rotter JI, Grody WW. Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.. Expert review of molecular diagnostics, 2012.
  72. Arboleda VA, Lee H, Sánchez FJ, Délot EC, Sandberg DE, Grody WW, Nelson SF, Vilain E. Targeted massively parallel sequencing provides comprehensive genetic diagnosis for patients with disorders of sex development.. Clinical genetics, 2012.
  73. Green RC, Berg JS, Berry GT, Biesecker LG, Dimmock DP, Evans JP, Grody WW, Hegde MR, Kalia S, Korf BR, Krantz I, McGuire AL, Miller DT, Murray MF, Nussbaum RL, Plon SE, Rehm HL, Jacob HJ. Exploring concordance and discordance for return of incidental findings from clinical sequencing.. Genetics in medicine : official journal of the American College of Medical Genetics, 2012.
  74. Ong FS, Deignan JL, Kuo JZ, Bernstein KE, Rotter JI, Grody WW, Das K. Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation.. Pharmacogenomics, 2012.
  75. Dry S, Grody WW, Papagni P. Stuck between a scalpel and a rock, or molecular pathology and legal-ethical issues in use of tissues for clinical care and research: what must a pathologist know?. American journal of clinical pathology, 2012.
  76. Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Grody WW, Nelson SF, Canick JA. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study.. Genetics in medicine : official journal of the American College of Medical Genetics, 2012.
  77. Grody WW. Expanded carrier screening and the law of unintended consequences: from cystic fibrosis to fragile X.. Genetics in medicine : official journal of the American College of Medical Genetics, 2011.
  78. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.. Genetics in medicine : official journal of the American College of Medical Genetics, 2011.
  79. Ong FS, Grody WW, Deignan JL. Privacy and data management in the era of massively parallel next-generation sequencing.. Expert review of molecular diagnostics, 2011.
  80. Zadeh N, Getzug T, Grody WW. Diagnosis and management of familial Mediterranean fever: integrating medical genetics in a dedicated interdisciplinary clinic.. Genetics in medicine : official journal of the American College of Medical Genetics, 2011.
  81. Deignan JL, Grody WW. Ordering genetic tests and interpreting the results.. Advances in oto-rhino-laryngology, 2011.
  82. Grody WW, Getzug T. Colchicine's other indication--effect of FDA action.. The New England journal of medicine, 2010.
  83. Quintero-Rivera F, Deignan JL, Peredo J, Grody WW, Crandall B, Sims M, Cederbaum SD. An exon 1 deletion in OTC identified using chromosomal microarray analysis in a mother and her two affected deceased newborns: implications for the prenatal diagnosis of ornithine transcarbamylase deficiency.. Molecular genetics and metabolism, 2010.
  84. Bender L, Silverman LM, Dinulos MB, Nickel J, Grody WW. Direct-to-consumer genotyping: are we ready for a brave new world?. Clinical chemistry, 2010.
  85. Wehling-Henricks M, Jordan MC, Gotoh T, Grody WW, Roos KP, Tidball JG. Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.. PloS one, 2010.
  86. Boudreault P, Baldwin EE, Fox M, Dutton L, Tullis L, Linden J, Kobayashi Y, Zhou J, Sinsheimer JS, Sininger Y, Grody WW, Palmer CG. Deaf adults' reasons for genetic testing depend on cultural affiliation: results from a prospective, longitudinal genetic counseling and testing study.. Journal of deaf studies and deaf education, 2010.
  87. Castellani C, Macek M, Cassiman JJ, Duff A, Massie J, ten Kate LP, Barton D, Cutting G, Dallapiccola B, Dequeker E, Girodon E, Grody W, Highsmith EW, Kääriäinen H, Kruip S, Morris M, Pignatti PF, Pypops U, Schwarz M, Soller M, Stuhrman M, Cuppens H. Benchmarks for cystic fibrosis carrier screening: a European consensus document.. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2010.
  88. Grody WW, Howell RR. The fate of newborn screening blood spots.. Pediatric research, 2010.
  89. Grody WW. Genetics in Hollywood: from real to reel.. Clinical genetics, 2010.
  90. Barker SD, Bale S, Booker J, Buller A, Das S, Friedman K, Godwin AK, Grody WW, Highsmith E, Kant JA, Lyon E, Mao R, Monaghan KG, Payne DA, Pratt VM, Schrijver I, Shrimpton AE, Spector E, Telatar M, Toji L, Weck K, Zehnbauer B, Kalman LV. Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing.. The Journal of molecular diagnostics : JMD, 2009.
  91. Rosove MH, Grody WW. Should we be applying warfarin pharmacogenetics to clinical practice? No, not now.. Annals of internal medicine, 2009.
  92. Palmer CG, Martinez A, Fox M, Zhou J, Shapiro N, Sininger Y, Grody WW, Schimmenti LA. A prospective, longitudinal study of the impact of GJB2/GJB6 genetic testing on the beliefs and attitudes of parents of deaf and hard-of-hearing infants.. American journal of medical genetics. Part A, 2009.
  93. Gau CL, Rosenblatt RA, Cerullo V, Lay FD, Dow AC, Livesay J, Brunetti-Pierri N, Lee B, Cederbaum SD, Grody WW, Lipshutz GS. Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector.. Molecular therapy : the journal of the American Society of Gene Therapy, 2009.
  94. Grody WW. Cystic fibrosis testing comes of age.. The Journal of molecular diagnostics : JMD, 2009.
  95. Pullarkat ST, Pullarkat V, Kroft SH, Wilson CS, Ahsanuddin AN, Mann KP, Thein M, Grody WW, Brynes RK. Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia.. Journal of hematopathology, 2009.
  96. ten Bosch JR, Grody WW. Keeping up with the next generation: massively parallel sequencing in clinical diagnostics.. The Journal of molecular diagnostics : JMD, 2008.
  97. Mumenthaler SM, Rozengurt N, Livesay JC, Sabaghian A, Cederbaum SD, Grody WW. Disruption of arginase II alters prostate tumor formation in TRAMP mice.. The Prostate, 2008.
  98. Schimmenti LA, Martinez A, Telatar M, Lai CH, Shapiro N, Fox M, Warman B, McCarra M, Crandall B, Sininger Y, Grody WW, Palmer CG. Infant hearing loss and connexin testing in a diverse population.. Genetics in medicine : official journal of the American College of Medical Genetics, 2008.
  99. Grody WW, Richards CS. New quality assurance standards for rare disease testing.. Genetics in medicine : official journal of the American College of Medical Genetics, 2008.
  100. Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, Lyon E, Ward BE, Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.. Genetics in medicine : official journal of the American College of Medical Genetics, 2008.
  101. Mumenthaler SM, Yu H, Tze S, Cederbaum SD, Pegg AE, Seligson DB, Grody WW. Expression of arginase II in prostate cancer.. International journal of oncology, 2008.
  102. Deignan JL, Marescau B, Livesay JC, Iyer RK, De Deyn PP, Cederbaum SD, Grody WW. Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia.. Molecular genetics and metabolism, 2007.
  103. Grody WW, Cutting GR, Watson MS. The Cystic Fibrosis mutation "arms race": when less is more.. Genetics in medicine : official journal of the American College of Medical Genetics, 2007.
  104. Deignan JL, Cederbaum SD, Grody WW. Contrasting features of urea cycle disorders in human patients and knockout mouse models.. Molecular genetics and metabolism, 2007.
  105. Palmer CG, Martinez A, Fox M, Sininger Y, Grody WW, Schimmenti LA. Ethnic differences in parental perceptions of genetic testing for deaf infants.. Journal of genetic counseling, 2007.
  106. Deignan JL, Livesay JC, Shantz LM, Pegg AE, O'Brien WE, Iyer RK, Cederbaum SD, Grody WW. Polyamine homeostasis in arginase knockout mice.. American journal of physiology. Cell physiology, 2007.
  107. Blase T, Martinez A, Grody WW, Schimmenti L, Palmer CG. Sharing GJB2/GJB6 genetic test information with family members.. Journal of genetic counseling, 2007.
  108. Lebo RV, Grody WW. Testing and reporting ACMG cystic fibrosis mutation panel results.. Genetic testing, 2007.
  109. Lebo RV, Grody WW. Variable penetrance and expressivity of the splice altering 5T sequence in the cystic fibrosis gene.. Genetic testing, 2007.
  110. Elshimali YI, Grody WW. The clinical significance of circulating tumor cells in the peripheral blood.. Diagnostic molecular pathology : the American journal of surgical pathology, part B, 2006.
  111. Kern RM, Yang Z, Kim PS, Grody WW, Iyer RK, Cederbaum SD. Arginase induction by sodium phenylbutyrate in mouse tissues and human cell lines.. Molecular genetics and metabolism, 2006.
  112. Deignan JL, Livesay JC, Yoo PK, Goodman SI, O'Brien WE, Iyer RK, Cederbaum SD, Grody WW. Ornithine deficiency in the arginase double knockout mouse.. Molecular genetics and metabolism, 2006.
  113. Keen-Kim D, Grody WW, Richards CS. Microelectronic array system for molecular diagnostic genotyping: Nanogen NanoChip 400 and molecular biology workstation.. Expert review of molecular diagnostics, 2006.
  114. Ramsden SC, Deans Z, Robinson DO, Mountford R, Sistermans EA, Grody WW, McQuaid S, Patton SJ, Stenhouse SA. Monitoring standards for molecular genetic testing in the United Kingdom, the Netherlands, and Ireland.. Genetic testing, 2006.
  115. Palmer CG, Martinez A, Sininger Y, Shapiro N, Grody WW, Schimmenti LA. Prelingual siblings of children with GJB2 hearing loss: issues to consider.. Archives of otolaryngology--head & neck surgery, 2005.
  116. Chen B, O' Connell CD, Boone DJ, Amos JA, Beck JC, Chan MM, Farkas DH, Lebo RV, Richards CS, Roa BB, Silverman LM, Barton DE, Bejjani BA, Belloni DR, Bernacki SH, Caggana M, Charache P, Dequeker E, Ferreira-Gonzalez A, Friedman KJ, Greene CL, Grody WW, Highsmith WE, Hinkel CS, Kalman LV, Lubin IM, Lyon E, Payne DA, Pratt VM, Rohlfs E, Rundell CA, Schneider E, Willey AM, Williams LO, Willey JC, Winn-Deen ES, Wolff DJ. Developing a sustainable process to provide quality control materials for genetic testing.. Genetics in medicine : official journal of the American College of Medical Genetics, 2005.
  117. Maddalena A, Bale S, Das S, Grody W, Richards S, ACMG Laboratory Quality Assurance Committee. Technical standards and guidelines: molecular genetic testing for ultra-rare disorders.. Genetics in medicine : official journal of the American College of Medical Genetics, 2005.
  118. Spector EB, Grody WW, Matteson CJ, Palomaki GE, Bellissimo DB, Wolff DJ, Bradley LA, Prior TW, Feldman G, Popovich BW, Watson MS, Richards CS. Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories.. Genetics in medicine : official journal of the American College of Medical Genetics, 2005.
  119. Jarvis M, Iyer RK, Williams LO, Noll WW, Thomas K, Telatar M, Grody WW. A novel method for creating artificial mutant samples for performance evaluation and quality control in clinical molecular genetics.. The Journal of molecular diagnostics : JMD, 2005.
  120. Ogino S, Flodman P, Wilson RB, Gold B, Grody WW. Risk calculations for cystic fibrosis in neonatal screening by immunoreactive trypsinogen and CFTR mutation tests.. Genetics in medicine : official journal of the American College of Medical Genetics, 2005.
  121. Schimmenti LA, Martinez A, Fox M, Crandall B, Shapiro N, Telatar M, Sininger Y, Grody WW, Palmer CG. Genetic testing as part of the early hearing detection and intervention (EHDI) process.. Genetics in medicine : official journal of the American College of Medical Genetics, 2004.
  122. Ogino S, Wilson RB, Gold B, Hawley P, Grody WW. Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening.. Genetics in medicine : official journal of the American College of Medical Genetics, 2004.
  123. Tsongalis GJ, Belloni DR, Grody WW. Cystic fibrosis mutation analysis: how many is enough?. Genetics in medicine : official journal of the American College of Medical Genetics, 2004.
  124. Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger K, Mennuti M, Palomaki GE, Popovich BW, Pratt VM, Rohlfs EM, Strom CM, Richards CS, Witt DR, Grody WW. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel.. Genetics in medicine : official journal of the American College of Medical Genetics, 2004.
  125. Amos J, Grody W. Development and integration of molecular genetic tests into clinical practice: the US experience.. Expert review of molecular diagnostics, 2004.
  126. Ogino S, Wilson RB, Grody WW. Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR mutation.. Journal of medical genetics, 2004.
  127. Cederbaum SD, Yu H, Grody WW, Kern RM, Yoo P, Iyer RK. Arginases I and II: do their functions overlap?. Molecular genetics and metabolism, 2004.
  128. Richards CS, Grody WW. Prenatal screening for cystic fibrosis: past, present and future.. Expert review of molecular diagnostics, 2004.
  129. Palomaki GE, Haddow JE, Bradley LA, Richards CS, Stenzel TT, Grody WW. Estimated analytic validity of HFE C282Y mutation testing in population screening: the potential value of confirmatory testing.. Genetics in medicine : official journal of the American College of Medical Genetics, 2003.
  130. Grody WW. Quest for controls in molecular genetics.. The Journal of molecular diagnostics : JMD, 2003.
  131. Yu H, Yoo PK, Aguirre CC, Tsoa RW, Kern RM, Grody WW, Cederbaum SD, Iyer RK. Widespread expression of arginase I in mouse tissues. Biochemical and physiological implications.. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2003.
  132. Richards CS, Grody WW. Alternative approaches to proficiency testing in molecular genetics.. Clinical chemistry, 2003.
  133. Venegas PB, Novak JM, Oscar CA, Sánchez FL, Gutiérrez IG, Rivera JM, Salas JP, Montero JF, Grody WW. Cystic fibrosis mutations in Costa Rica.. Human biology, 2003.
  134. Grody WW. Ethical issues raised by genetic testing with oligonucleotide microarrays.. Molecular biotechnology, 2003.
  135. Watson MS, Desnick RJ, Grody WW, Mennuti MT, Popovich BW, Richards CS. Cystic fibrosis carrier screening: issues in implementation.. Genetics in medicine : official journal of the American College of Medical Genetics, 2002.
  136. Sharma P, Rosenbaum AL, Vives T, Grody WW, Demer JL. Discordant pursuit asymmetry and esotropia in monozygous twins.. American journal of ophthalmology, 2002.
  137. Kim PS, Iyer RK, Lu KV, Yu H, Karimi A, Kern RM, Tai DK, Cederbaum SD, Grody WW. Expression of the liver form of arginase in erythrocytes.. Molecular genetics and metabolism, 2002.
  138. Iyer RK, Kim HK, Tsoa RW, Grody WW, Cederbaum SD. Cloning and characterization of human agmatinase.. Molecular genetics and metabolism, 2002.
  139. Grody WW. Molecular genetic risk screening.. Annual review of medicine, 2001.
  140. Yu H, Iyer RK, Kern RM, Rodriguez WI, Grody WW, Cederbaum SD. Expression of arginase isozymes in mouse brain.. Journal of neuroscience research, 2001.
  141. Iyer RK, Kim PS, Bando JM, Lu KV, Gregg JP, Grody WW. A multiethnic study of Delta32ccr5 and ccr2b-V64I allele distribution in four Los Angeles populations.. Diagnostic molecular pathology : the American journal of surgical pathology, part B, 2001.
  142. Grody WW, Griffin JH, Taylor AK, Korf BR, Heit JA, ACMG Factor V. Leiden Working Group. American College of Medical Genetics consensus statement on factor V Leiden mutation testing.. Genetics in medicine : official journal of the American College of Medical Genetics, 2001.
  143. Grody WW, Desnick RJ. Cystic fibrosis population carrier screening: here at last--are we ready?. Genetics in medicine : official journal of the American College of Medical Genetics, 2001.
  144. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ, Subcommittee on Cystic Fibrosis Screening, Accreditation of Genetic Services Committee, ACMG. Ameri. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening.. Genetics in medicine : official journal of the American College of Medical Genetics, 2001.
  145. Grody WW. Ethical ramifications of genetic analysis using DNA arrays.. Methods in molecular biology (Clifton, N.J.), 2001.
  146. Rohlfs EM, Chung CH, Yang Q, Skrzynia C, Grody WW, Graham ML, Silverman LM. In-frame deletions of BRCA1 may define critical functional domains.. Human genetics, 2000.
  147. Emmanouilides C, Rosen P, Telatar M, Malone R, Bosserman L, Menco H, Patel R, Barstis J, Grody WW. Excellent tolerance of rituximab when given after mitoxantrone/cyclophosphamide: an effective and safe combination for indolent non-Hodgkin's lymphoma.. Clinical lymphoma, 2000.
  148. Telatar M, Grody WW. Molecular genetic testing for familial Mediterranean fever.. Molecular genetics and metabolism, 2000.
  149. Grody WW. Cystic fibrosis: molecular diagnosis, population screening, and public policy.. Archives of pathology & laboratory medicine, 1999.
  150. Stass SA, Grody WW. Molecular pathology: role in improving patient outcome: Overview.. Archives of pathology & laboratory medicine, 1999.
  151. Noll WW, Belloni DR, Stenzel TT, Grody WW. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.. Nature genetics, 1999.
  152. Haddow JE, Bradley LA, Palomaki GE, Doherty RA, Bernhardt BA, Brock DJ, Cheuvront B, Cunningham GC, Donnenfeld AE, Erickson JL, Erlich HA, Ferrie RM, FitzSimmons SC, Greene MF, Grody WW, Haddow PK, Harris H, Holmes LB, Howell RR, Katz M, Klinger KW, Kloza EM, LeFevre ML, Little S, Loeben G, McGovern M, Pyeritz RE, Rowley PT, Saiki RK, Short MP, Tabone J, Wald NJ, Wilker NL, Witt DR. Issues in implementing prenatal screening for cystic fibrosis: results of a working conference.. Genetics in medicine : official journal of the American College of Medical Genetics, 1999.
  153. Cabello GM, Moreira AF, Horovitz D, Correia P, Santa Rosa A, Llerena J, Greg J, Grody WW, Degrave WM, Fernandes O, Cabello PH. Cystic fibrosis: low frequency of DF508 mutation in 2 population samples from Rio de Janeiro, Brazil.. Human biology, 1999.
  154. Grizzle W, Grody WW, Noll WW, Sobel ME, Stass SA, Trainer T, Travers H, Weedn V, Woodruff K. Recommended policies for uses of human tissue in research, education, and quality control. Ad Hoc Committee on Stored Tissue, College of American Pathologists.. Archives of pathology & laboratory medicine, 1999.
  155. Grody WW, Pyeritz RE. Report card on molecular genetic testing: room for improvement?. JAMA, 1999.
  156. Apple SK, Hecht JR, Lewin DN, Jahromi SA, Grody WW, Nieberg RK. Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis.. Human pathology, 1999.
  157. Wackym PA, Kerner MM, Grody WW. Molecular temporal bone pathology: III. Genotyping of the deltaF508 deletion in the DNA of patients with cystic fibrosis.. The Laryngoscope, 1998.
  158. Grody WW, Desnick RJ, Carpenter NJ, Noll WW. Diversity of cystic fibrosis mutation-screening practices.. American journal of human genetics, 1998.
  159. Iyer RK, Bando JM, Jenkinson CP, Vockley JG, Kim PS, Kern RM, Cederbaum SD, Grody WW. Cloning and characterization of the mouse and rat type II arginase genes.. Molecular genetics and metabolism, 1998.
  160. Iyer R, Jenkinson CP, Vockley JG, Kern RM, Grody WW, Cederbaum S. The human arginases and arginase deficiency.. Journal of inherited metabolic disease, 1998.
  161. Gregg JP, Yamane AJ, Grody WW. Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations.. American journal of medical genetics, 1997.
  162. Geschwind DH, Perlman S, Grody WW, Telatar M, Montermini L, Pandolfo M, Gatti RA. Friedreich's ataxia GAA repeat expansion in patients with recessive or sporadic ataxia.. Neurology, 1997.
  163. Gregg JP, Grody WW. Diagnostic molecular genetics: current applications and future technologies.. Pediatric annals, 1997.
  164. Grody WW, Watson MS. Those elusive molecular diagnostics CPT codes.. Diagnostic molecular pathology : the American journal of surgical pathology, part B, 1997.
  165. Grody WW, Dunkel-Schetter C, Tatsugawa ZH, Fox MA, Fang CY, Cantor RM, Novak JM, Bass HN, Crandall BF. PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population.. American journal of human genetics, 1997.
  166. Li PX, Cheng L, Wen DR, Wissmann PB, Cheng J, Grody WW, Cochran AJ. Demonstration of cytoplasmic tyrosinase mRNA in tissue-cultured cells by reverse transcription (RT) in situ polymerase chain reaction (PCR) and RT PCR in situ hybridization.. Diagnostic molecular pathology : the American journal of surgical pathology, part B, 1997.
  167. Donovan JA, Simmons FA, Esrason KT, Jamehdor M, Busuttil RW, Novak JM, Grody WW. Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping.. Transplantation, 1997.
  168. Fang CY, Dunkel-Schetter C, Tatsugawa ZH, Fox MA, Bass HN, Crandall BF, Grody WW. Attitudes toward genetic carrier screening for cystic fibrosis among pregnant women: the role of health beliefs and avoidant coping style.. Women's health (Hillsdale, N.J.), 1997.
  169. Vockley JG, Jenkinson CP, Shukla H, Kern RM, Grody WW, Cederbaum SD. Cloning and characterization of the human type II arginase gene.. Genomics, 1996.
  170. Wissmann PB, Goodman BK, Vockley JG, Kern RM, Cederbaum SD, Grody WW. Delivery of cytosolic liver arginase into the mitochondrial matrix space: a possible novel site for gene replacement therapy.. Somatic cell and molecular genetics, 1996.
  171. Vockley JG, Goodman BK, Tabor DE, Kern RM, Jenkinson CP, Grody WW, Cederbaum SD. Loss of function mutations in conserved regions of the human arginase I gene.. Biochemical and molecular medicine, 1996.
  172. Grody WW, Sobel ME. Update on informed consent for stored tissue research.. Diagnostic molecular pathology : the American journal of surgical pathology, part B, 1996.
  173. Jenkinson CP, Grody WW, Cederbaum SD. Comparative properties of arginases.. Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology, 1996.
  174. Lovell MA, Grody WW. Molecular pathology 1995. Birth of an association [meeting report].. Diagnostic molecular pathology : the American journal of surgical pathology, part B, 1996.
  175. Apple SK, Hecht JR, Novak JM, Nieberg RK, Rosenthal DL, Grody WW. Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears.. American journal of clinical pathology, 1996.
  176. Goldstein NS, Bégin LR, Grody WW, Novak JM, Qian J, Bostwick DG. Minimal or no cancer in radical prostatectomy specimens. Report of 13 cases of the "vanishing cancer phenomenon".. The American journal of surgical pathology, 1995.
  177. Grody WW. Molecular pathology, informed consent, and the paraffin block.. Diagnostic molecular pathology : the American journal of surgical pathology, part B, 1995.
  178. Tatsugawa ZH, Fox MA, Fang CY, Novak JM, Cantor RM, Bass HN, Dunkel-Schetter C, Crandall BF, Grody WW. Education and testing strategy for large-scale cystic fibrosis carrier screening.. Journal of genetic counseling, 1994.
  179. Grody WW. Proficiency testing in diagnostic molecular pathology.. Diagnostic molecular pathology : the American journal of surgical pathology, part B, 1994.
  180. Gu Y, Lugenbeel KA, Vockley JG, Grody WW, Nelson DL. A de novo deletion in FMR1 in a patient with developmental delay.. Human molecular genetics, 1994.
  181. Grody WW. The coming era of cancer genetic screening.. Diagnostic molecular pathology : the American journal of surgical pathology, part B, 1994.
  182. Dubinett SM, Huang M, Lichtenstein A, McBride WH, Wang J, Markovitz G, Kelley D, Grody WW, Mintz LE, Dhanani S. Tumor necrosis factor-alpha plays a central role in interleukin-2-induced pulmonary vascular leak and lymphocyte accumulation.. Cellular immunology, 1994.
  183. Goodman BK, Klein D, Tabor DE, Vockley JG, Cederbaum SD, Grody WW. Functional and molecular analysis of liver arginase promoter sequences from man and Macaca fascicularis.. Somatic cell and molecular genetics, 1994.
  184. Grody WW. DMP News and Comment.. Diagnostic molecular pathology : the American journal of surgical pathology, part B, 1994.
  185. Vockley JG, Tabor DE, Kern RM, Goodman BK, Wissmann PB, Kang DS, Grody WW, Cederbaum SD. Identification of mutations (D128G, H141L) in the liver arginase gene of patients with hyperargininemia.. Human mutation, 1994.
  186. Grody WW, Chang RJ, Panagiotis NM, Matz D, Cederbaum SD. Menstrual cycle and gonadal steroid effects on symptomatic hyperammonaemia of urea-cycle-based and idiopathic aetiologies.. Journal of inherited metabolic disease, 1994.
  187. Grody WW, Kronquist KE, Lee EU, Edmond J, Rome LH. PCR-based cystic fibrosis (CF) carrier screening in a first-year medical student biochemistry laboratory.. American journal of human genetics, 1993.
  188. Grody WW. Molecular genetics. Introduction.. Archives of pathology & laboratory medicine, 1993.
  189. Grody WW, Kern RM, Klein D, Dodson AE, Wissman PB, Barsky SH, Cederbaum SD. Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme.. Human genetics, 1993.
  190. Dubinett SM, Huang M, Dhanani S, Kelley D, Lichtenstein A, Grody WW, Mintz LE. In situ regulation of pulmonary macrophage TNF-alpha mRNA expression by IL2.. Chest, 1993.
  191. Klein D, Grody WW, Tabor DE, Cederbaum SD. Pitfalls of restriction endonuclease digestion for direct detection of point mutations.. Clinical chemistry, 1992.
  192. Grody WW, Klein D, Dodson AE, Kern RM, Wissmann PB, Goodman BK, Bassand P, Marescau B, Kang SS, Leonard JV. Molecular genetic study of human arginase deficiency.. American journal of human genetics, 1992.
  193. Lewis W, Grody WW. AIDS and the heart: Review and consideration of pathogenetic mechanisms.. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, 1992.
  194. Klein D, Dodson AE, Tabor DE, Cederbaum SD, Grody WW. Effect of an adjacent base on detection of a point mutation by restriction enzyme digestion.. Somatic cell and molecular genetics, 1991.
  195. Fain JS, Bryan RN, Cheng L, Lewin KJ, Porter DD, Grody WW. Rapid diagnosis of Legionella infection by a nonisotopic in situ hybridization method.. American journal of clinical pathology, 1991.
  196. Grody WW, Cheng L, Lewis W. Infection of the heart by the human immunodeficiency virus.. The American journal of cardiology, 1990.
  197. Nguyen J, Charmley P, Grody WW, Cederbaum SD, King MC, Gatti RA. Genetic linkage group (ARG1-D6S33-MYB) on chromosome 6q containing the arginase-1 and MYB genes.. Cytogenetics and cell genetics, 1990.
  198. Grody WW, Argyle C, Kern RM, Dizikes GJ, Spector EB, Strickland AD, Klein D, Cederbaum SD. Differential expression of the two human arginase genes in hyperargininemia. Enzymatic, pathologic, and molecular analysis.. The Journal of clinical investigation, 1989.
  199. Lai-Goldman M, Lai E, Grody WW. Detection of human immunodeficiency virus (HIV) infection in formalin-fixed, paraffin-embedded tissues by DNA amplification.. Nucleic acids research, 1988.
  200. Grody WW, Dizikes GJ, Cederbaum SD. Human arginase isozymes.. Isozymes, 1987.
  201. Kidd JR, Dizikes GJ, Grody WW, Cederbaum SD, Kidd KK. A PvuII RFLP for the human liver arginase (ARG1) gene.. Nucleic acids research, 1986.
  202. Dizikes GJ, Grody WW, Kern RM, Cederbaum SD. Isolation of human liver arginase cDNA and demonstration of nonhomology between the two human arginase genes.. Biochemical and biophysical research communications, 1986.
  203. Grody WW, Jobst S, Keesey J, Herrmann C, Naeim F. Pathologic evaluation of thymic hyperplasia in myasthenia gravis and Lambert-Eaton myasthenic syndrome.. Archives of pathology & laboratory medicine, 1986.
  204. Sparkes RS, Dizikes GJ, Klisak I, Grody WW, Mohandas T, Heinzmann C, Zollman S, Lusis AJ, Cederbaum SD. The gene for human liver arginase (ARG1) is assigned to chromosome band 6q23.. American journal of human genetics, 1986.